mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-06 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-06 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
3e-06 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-06 |